Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study)

Figure 2

Algorithm for the screening and follow-up of HIVW. HIVW: HIV-infected women aged 26–65 years. HPV testing: Nucleic acid extraction from cervical samples (by NucliSENS® EasyMAG™, bioMérieux bv, France) followed by PCR amplification of a 450-base pair fragment of ORF L1 using the degenerate primer pair ELSI-f and ELSI-r.

Back to article page